SCHEMBL4188580

SCHEMBL4188580

Cc1ccc(NS(=O)(=O)C(C#N)=Cc2ccc(O)cc2)c(C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYTH2 Q99418 1/20 0.44
HPGD P15428 2/20 0.42
PKM P14618 1/20 0.42
PTGES2 Q9H7Z7 1/20 0.41
KDM4E B2RXH2 2/20 0.40
EGFR P00533 1/20 0.40
RAB9A P51151 3/20 0.39
MAPT P10636 2/20 0.39
JAK2 O60674 1/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 4/20 0.39
GAA P10253 3/20 0.39
ALDH1A1 P00352 3/20 0.39
TSHR P16473 2/20 0.39
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
THRB P10828 2/20 0.38
POLB P06746 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188573 1.00 CYTH2 (0.44) CYTH2HPGDPKMPTGES2KDM4E
SCHEMBL4188578 1.00 CYTH2 (0.44) CYTH2HPGDPKMPTGES2KDM4E
SCHEMBL4179123 0.89 PTGES2 (0.54) HPGDPKMPTGES2KDM4ERAB9A
SCHEMBL4179125 0.89 PTGES2 (0.54) HPGDPKMPTGES2KDM4ERAB9A
SCHEMBL4185856 0.89 PTGES2 (0.41) HPGDPKMPTGES2KDM4EEGFR
SCHEMBL4179117 0.89 PTGES2 (0.54) HPGDPKMPTGES2KDM4ERAB9A
SCHEMBL4185860 0.89 PTGES2 (0.41) HPGDPKMPTGES2KDM4EEGFR
SCHEMBL4185852 0.89 PTGES2 (0.41) HPGDPKMPTGES2KDM4EEGFR
SCHEMBL4171795 0.88 KMT2A (0.41) CYTH2HPGDPKMPTGES2KDM4E
SCHEMBL4171800 0.88 KMT2A (0.41) CYTH2HPGDPKMPTGES2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 CYTH2 2857/4885HPGD 2134/4885PKM 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.